• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL CLEO 90 SUBCUTANEOUS INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL CLEO 90 SUBCUTANEOUS INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Skin Discoloration (2074)
Event Date 01/28/2020
Event Type  malfunction  
Event Description
It was reported that, with use of the device, a discoloration was noted at the infusion site.No medical or surgical intervention was reported.
 
Manufacturer Narrative
No device was returned.The following operations were reviewed, in order to verify that the operations were properly performed, also records were reviewed, in order to ensure that complied with gmp (good manufacturing practices) requirements and procedures: the assemble base with cannula to inserter operation was reviewed to ensure that the cannula is properly assembled; no discrepancies were found.The operators that perform critical operations such as bond skin adhesive film onto flange of sleeve and the skin adhesive inspections using a monitor are certified.The operator performs the visual inspection of the adhesive using the skin adhesive inspection.Four samples from reported lot number were taken from production floor and tested for in-process testing and no discrepancies were found.Visual inspection of thirty-two samples from a different lot number were taken from production line and were visually inspected in order to verify that the spring is not released.Results: no discrepancies were detected.The retractor assemblies were 100 percent visually inspected by the production personnel to assure that the needle is properly threaded.Production personnel verified 100 percent that parts were not damaged (including scratches) or distorted/warped.Quality personnel verifies 100 percent that the needle tip is up, and the blunt end is fully seated and verify the length while still in the needle hub on the pallet.No root cause could be determined, as no samples or pictures were received for evaluation.No corrective actions are required since the complaint could not be confirmed.A device history record (dhr) review was performed.No problems or issues were identified during the dhr review.No product information has been provided to date.This remediation mdr was generated under protocol (b)(4), as a result of warning letter cms# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO 90 SUBCUTANEOUS INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
jim vegel
6000 nathan lane north
im einsatz uber agap2
minneapolis, MN 55442
MDR Report Key15353838
MDR Text Key305373950
Report Number3012307300-2022-17651
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-